Ken Cacciatore Profile - TD Cowen Analyst
102 Followers
Ken Cacciatore's Stock Coverage
| 4502Takeda Pharmaceutical Co | Dec 19, 2024 | BUY | Reiterated | ¥5,135.00 | 1Ratings | +23.30% | ||
| BHCBausch Health Companies | Jun 16, 2023 | HOLD | Downgraded | ― | 6Ratings | -19.46% | ||
| TAKTakeda Pharmaceutical Company | May 16, 2023 | BUY | Reiterated | $25.00 | 6Ratings | -7.77% | ||
| EYPTEyePoint Pharmaceuticals | Jan 04, 2023 | BUY | Reiterated | $35.00 | 3Ratings | +136.47% | ||
| BHVNBiohaven Ltd. | Nov 07, 2022 | BUY | Reiterated | $25.00 | 1Ratings | +92.80% | ||
| BLCOBausch + Lomb Corporation | Jul 28, 2022 | BUY | Reiterated | $35.00 | 2Ratings | +16.50% | ||
| AUPHAurinia Pharmaceuticals | May 10, 2022 | BUY | Reiterated | $30.00 | 6Ratings | -12.40% | ||
| JAZZJazz Pharmaceuticals | May 05, 2022 | BUY | Reiterated | $225.00 | 30Ratings | +2.58% | ||
| AMRNAmarin | May 04, 2022 | BUY | Reiterated | $9.00 | 7Ratings | -29.40% | ||
| MOLNMolecular Partners AG | Mar 16, 2022 | BUY | Reiterated | CHF50.00 | 2Ratings | -68.90% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Ken Cacciatore activity FAQ
What is the performance of Ken Cacciatore's recommendations?
The percentage of profitable recommendations made by Ken Cacciatore is 41.63%, and the average return per transaction is -0.40%.
What stocks does Ken Cacciatore cover?
Ken Cacciatore mostly covers Takeda Pharmaceutical Co, Bausch Health Companies, Takeda Pharmaceutical Company stocks.
What was Ken Cacciatore's most profitable rating?
Ken Cacciatore’s most profitable rating was a buy on EyePoint Pharmaceuticals stock on Jan 04, 2023. The return on the trade was 498.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here
